Tole, Italy

Antonella Ferrieri

This inventor holds 2 USPTO granted patents. Top assignee: Alfa Wassermann, Inc.. Active years: 1994-1999.


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 32(Granted Patents)


Location History:

  • Tole, IT (1994)
  • Bologna, IT (1999)

Company Filing History:


Years Active: 1994-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Antonella Ferrieri: Innovator in Pharmaceutical Applications

Introduction

Antonella Ferrieri is a prominent inventor based in Tole, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for gastrointestinal disorders. With a total of 2 patents, her work focuses on innovative applications of rifaximin, an antibiotic known for its effectiveness in treating various conditions.

Latest Patents

Ferrieri's latest patents include groundbreaking research on the use of rifaximin and pharmaceutical compositions containing it. One patent addresses the treatment of diarrheal symptoms associated with cryptosporidiosis in patients with severe immunodepression, such as those suffering from AIDS or undergoing chemotherapy. The second patent highlights the use of rifaximin in treating gastric dyspepsia caused by Helicobacter pylori, showcasing its versatility in oral pharmaceutical forms.

Career Highlights

Antonella Ferrieri is affiliated with Alfa Wassermann, Inc., where she continues to advance her research and development efforts. Her innovative approaches have positioned her as a key figure in the pharmaceutical industry, contributing to improved patient outcomes through her inventions.

Collaborations

Ferrieri has collaborated with notable colleagues, including Pietro Caramello and Leone G Rotini. These partnerships have fostered a collaborative environment that enhances the development of effective pharmaceutical solutions.

Conclusion

Antonella Ferrieri's contributions to the pharmaceutical field through her patents and collaborations demonstrate her commitment to innovation and improving healthcare. Her work continues to impact the treatment of gastrointestinal disorders, making her a significant figure in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…